BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9341097)

  • 1. The relevance of mechanistic data to the interpretation and extrapolation to humans of rodent carcinogenicity data.
    Ashby J
    Environ Health Perspect; 1997 Sep; 105(9):902-3. PubMed ID: 9341097
    [No Abstract]   [Full Text] [Related]  

  • 2. Weight of evidence versus weight of speculation to evaluate the alpha2u-globulin hypothesis.
    Melnick RL; Kohn MC; Huff J
    Environ Health Perspect; 1997 Sep; 105(9):904-6. PubMed ID: 9341100
    [No Abstract]   [Full Text] [Related]  

  • 3. alpha2u-Globulin nephropathy and ravens: do ravens of a different feather flock together?
    de la Iglesia FA; Gough AW; Sigler RE
    Environ Health Perspect; 1997 Sep; 105(9):903-4. PubMed ID: 9341098
    [No Abstract]   [Full Text] [Related]  

  • 4. Doubting nongenotoxic mechanisms of renal cancer: comparing apples and oranges in the alpha2u-globulin hypothesis.
    Dietrich DR
    Environ Health Perspect; 1997 Sep; 105(9):898-902. PubMed ID: 9341099
    [No Abstract]   [Full Text] [Related]  

  • 5. Propylene glycol monomethyl ether (PGME): inhalation toxicity and carcinogenicity in Fischer 344 rats and B6C3F1 mice.
    Spencer PJ; Crissman JW; Stott WT; Corley RA; Cieszlak FS; Schumann AM; Hardisty JF
    Toxicol Pathol; 2002; 30(5):570-9. PubMed ID: 12371666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation of male rat renal tubule tumors.
    Rodgers IS; Baetcke KP
    Environ Health Perspect; 1993 Dec; 101 Suppl 6(Suppl 6):45-52. PubMed ID: 7517352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting alternative approaches to the assessment of carcinogenic risk.
    Downes N
    Toxicol Pathol; 2010 Feb; 38(2):324-7. PubMed ID: 20124498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha 2-Urinary globulin-associated nephropathy as a mechanism of renal tubule cell carcinogenesis in male rats.
    Swenberg JA; Lehman-McKeeman LD
    IARC Sci Publ; 1999; (147):95-118. PubMed ID: 10457913
    [No Abstract]   [Full Text] [Related]  

  • 9. Hazard evaluation of chemicals that cause accumulation of alpha 2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats.
    Hard GC; Rodgers IS; Baetcke KP; Richards WL; McGaughy RE; Valcovic LR
    Environ Health Perspect; 1993 Mar; 99():313-49. PubMed ID: 7686485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible mechanisms of induction of renal tubule cell neoplasms in rats associated with alpha 2u-globulin: role of protein accumulation versus ligand delivery to the kidney.
    Melnick RL; Kohn MC
    IARC Sci Publ; 1999; (147):119-37. PubMed ID: 10457914
    [No Abstract]   [Full Text] [Related]  

  • 11. Data quality in predictive toxicology: reproducibility of rodent carcinogenicity experiments.
    Gottmann E; Kramer S; Pfahringer B; Helma C
    Environ Health Perspect; 2001 May; 109(5):509-14. PubMed ID: 11401763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rodent carcinogenicity bioassay: past, present, and future.
    Boorman GA; Maronpot RR; Eustis SL
    Toxicol Pathol; 1994; 22(2):105-11. PubMed ID: 7973358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 2u-globulin nephropathy and carcinogenicity following exposure to decalin (decahydronaphthalene) in F344/N rats.
    Dill JA; Lee KM; Renne RA; Miller RA; Fuciarelli AF; Gideon KM; Chan PC; Burka LT; Roycroft JH
    Toxicol Sci; 2003 Apr; 72(2):223-34. PubMed ID: 12660359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Criteria, rules and procedures adopted by IARC in evaluating risks from different carcinogenic agents for humans].
    IARC
    Vopr Onkol; 2007; 53(6):621-41. PubMed ID: 18416130
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention versus chemophobia: a defence of rodent carcinogenicity tests.
    Infante PF
    Lancet; 1991 Mar; 337(8740):538-40. PubMed ID: 1671901
    [No Abstract]   [Full Text] [Related]  

  • 17. Carcinogenicity of lipid-lowering drugs.
    Newman TB; Hulley SB
    JAMA; 1996 Jan; 275(1):55-60. PubMed ID: 8531288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striking the balance between the role of animal model and human data in hazard assessment.
    Calabrese EJ
    Hum Exp Toxicol; 1997 Apr; 16(4):186-7. PubMed ID: 9154438
    [No Abstract]   [Full Text] [Related]  

  • 19. Critique does not validate assumptions in the model on alpha 2u-globulin and renal carcinogenesis.
    Melnick RL
    Regul Toxicol Pharmacol; 1993 Oct; 18(2):365-8. PubMed ID: 7506437
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma.
    Radi Z; Bartholomew P; Elwell M; Vogel WM
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):456-63. PubMed ID: 24141031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.